Latest filing published 01 May 2026 for Emergent BioSolutions Inc..
Jessica Perl appears in our data through filings on Emergent BioSolutions Inc. shares, published by SEC (Form 4). Over a trading history stretching from 9 February 2025 to 29 April 2026, the count stands at 5 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 1 May 2026 came the latest disclosure, a share grant in Emergent BioSolutions Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations